HEADER TRANSFERASE/TRANSFERASE INHIBITOR 14-FEB-19 6NZM TITLE BRUTONS TYROSINE KINASE IN COMPLEX WITH COMPOUND 50. COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE BTK; COMPND 3 CHAIN: A, D; COMPND 4 SYNONYM: AGAMMAGLOBULINEMIA TYROSINE KINASE,ATK,B-CELL PROGENITOR COMPND 5 KINASE,BPK,BRUTON TYROSINE KINASE; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BTK, AGMX1, ATK, BPK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS BRUTONS TYROSINE KINASE BTK, TRANSFERASE, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.J.MARCOTTE REVDAT 2 19-JUN-19 6NZM 1 JRNL REVDAT 1 12-JUN-19 6NZM 0 JRNL AUTH B.T.HOPKINS,E.BAME,N.BELL,T.BOHNERT,J.K.BOWDEN-VERHOEK, JRNL AUTH 2 M.BUI,M.T.CANCILLA,P.CONLON,P.CULLEN,D.A.ERLANSON,J.FAN, JRNL AUTH 3 T.FUCHS-KNOTTS,S.HANSEN,S.HEUMANN,T.J.JENKINS,D.MARCOTTE, JRNL AUTH 4 B.MCDOWELL,E.MERTSCHING,E.NEGROU,K.L.OTIPOBY,U.PORECI, JRNL AUTH 5 M.J.ROMANOWSKI,D.SCOTT,L.SILVIAN,W.YANG,M.ZHONG JRNL TITL OPTIMIZATION OF NOVEL REVERSIBLE BRUTON'S TYROSINE KINASE JRNL TITL 2 INHIBITORS IDENTIFIED USING TETHERING-FRAGMENT-BASED JRNL TITL 3 SCREENS. JRNL REF BIOORG.MED.CHEM. V. 27 2905 2019 JRNL REFN ESSN 1464-3391 JRNL PMID 31138459 JRNL DOI 10.1016/J.BMC.2019.05.021 REMARK 2 REMARK 2 RESOLUTION. 1.72 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0238 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.72 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.31 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 90.7 REMARK 3 NUMBER OF REFLECTIONS : 52062 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.179 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 2637 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.72 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.76 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2085 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 49.09 REMARK 3 BIN R VALUE (WORKING SET) : 0.1570 REMARK 3 BIN FREE R VALUE SET COUNT : 104 REMARK 3 BIN FREE R VALUE : 0.2820 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4228 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 88 REMARK 3 SOLVENT ATOMS : 497 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.33 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.06000 REMARK 3 B22 (A**2) : -0.95000 REMARK 3 B33 (A**2) : 0.89000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.55000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.051 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.029 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.051 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.136 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.916 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4451 ; 0.014 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 4031 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6011 ; 1.944 ; 1.671 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9333 ; 1.527 ; 1.611 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 529 ; 7.033 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 226 ;33.075 ;22.212 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 772 ;13.992 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 25 ;19.731 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 545 ; 0.103 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4898 ; 0.010 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 989 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 8482 ; 3.891 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6NZM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-FEB-19. REMARK 100 THE DEPOSITION ID IS D_1000239718. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-AUG-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59589 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.730 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.10700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.73 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.91500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.38 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M AMMONIUM TARTRATE, 20% PEG3350, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 35.85450 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 380 REMARK 465 SER A 381 REMARK 465 LYS A 382 REMARK 465 ASN A 383 REMARK 465 ALA A 384 REMARK 465 PRO A 385 REMARK 465 SER A 386 REMARK 465 THR A 387 REMARK 465 ALA A 388 REMARK 465 GLY A 389 REMARK 465 LEU A 390 REMARK 465 GLY A 391 REMARK 465 TYR A 392 REMARK 465 GLY A 393 REMARK 465 SER A 394 REMARK 465 ARG A 468 REMARK 465 PRO A 469 REMARK 465 GLY D 380 REMARK 465 SER D 381 REMARK 465 LYS D 382 REMARK 465 ASN D 383 REMARK 465 ALA D 384 REMARK 465 PRO D 385 REMARK 465 SER D 386 REMARK 465 THR D 387 REMARK 465 ALA D 388 REMARK 465 GLY D 389 REMARK 465 LEU D 390 REMARK 465 GLY D 391 REMARK 465 TYR D 392 REMARK 465 GLY D 393 REMARK 465 SER D 394 REMARK 465 PRO D 469 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TRP A 395 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 395 CZ3 CH2 REMARK 470 GLN A 412 CG CD OE1 NE2 REMARK 470 GLU A 434 CG CD OE1 OE2 REMARK 470 GLU A 444 CG CD OE1 OE2 REMARK 470 GLU A 445 CG CD OE1 OE2 REMARK 470 LYS A 447 CG CD CE NZ REMARK 470 GLN A 467 CG CD OE1 NE2 REMARK 470 ILE A 470 CG1 CG2 CD1 REMARK 470 GLN A 496 CG CD OE1 NE2 REMARK 470 SER A 554 OG REMARK 470 VAL A 555 CG1 CG2 REMARK 470 HIS A 609 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 625 CG CD CE NZ REMARK 470 LYS A 637 CG CD CE NZ REMARK 470 LYS A 645 CE NZ REMARK 470 GLN D 412 CG CD OE1 NE2 REMARK 470 GLU D 434 CG CD OE1 OE2 REMARK 470 GLU D 444 CG CD OE1 OE2 REMARK 470 GLU D 445 CG CD OE1 OE2 REMARK 470 LYS D 447 CG CD CE NZ REMARK 470 GLN D 467 CG CD OE1 NE2 REMARK 470 ILE D 470 CG1 CG2 CD1 REMARK 470 GLN D 496 CG CD OE1 NE2 REMARK 470 THR D 552 OG1 CG2 REMARK 470 VAL D 555 CG1 CG2 REMARK 470 LYS D 625 CG CD CE NZ REMARK 470 LYS D 645 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS A 558 O HOH A 801 2.15 REMARK 500 O HOH A 1005 O HOH A 1007 2.16 REMARK 500 O HOH D 818 O HOH D 934 2.19 REMARK 500 O HOH A 978 O HOH A 1026 2.19 REMARK 500 OE2 GLU A 658 O HOH A 802 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 846 O HOH D 801 2545 1.99 REMARK 500 O GLY D 423 O HOH A 964 2555 2.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU D 507 CD GLU D 507 OE1 -0.067 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 405 -46.98 -131.77 REMARK 500 GLN A 424 -51.75 -137.49 REMARK 500 GLU A 488 97.03 -67.86 REMARK 500 ARG A 520 -10.40 83.57 REMARK 500 ASP A 521 43.94 -151.68 REMARK 500 GLU A 658 20.00 85.98 REMARK 500 LEU D 405 -51.72 -128.60 REMARK 500 GLN D 424 -49.17 -134.31 REMARK 500 GLU D 488 98.49 -67.40 REMARK 500 ARG D 520 -11.98 78.27 REMARK 500 GLU D 658 4.67 87.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1048 DISTANCE = 7.09 ANGSTROMS REMARK 525 HOH A1049 DISTANCE = 7.27 ANGSTROMS REMARK 525 HOH A1050 DISTANCE = 8.30 ANGSTROMS REMARK 525 HOH A1051 DISTANCE = 8.60 ANGSTROMS REMARK 525 HOH A1052 DISTANCE = 9.06 ANGSTROMS REMARK 525 HOH D1044 DISTANCE = 6.26 ANGSTROMS REMARK 525 HOH D1045 DISTANCE = 6.45 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue L9S A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue L9S D 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO D 702 DBREF 6NZM A 382 659 UNP Q06187 BTK_HUMAN 416 693 DBREF 6NZM D 382 659 UNP Q06187 BTK_HUMAN 416 693 SEQADV 6NZM GLY A 380 UNP Q06187 EXPRESSION TAG SEQADV 6NZM SER A 381 UNP Q06187 EXPRESSION TAG SEQADV 6NZM GLY D 380 UNP Q06187 EXPRESSION TAG SEQADV 6NZM SER D 381 UNP Q06187 EXPRESSION TAG SEQRES 1 A 280 GLY SER LYS ASN ALA PRO SER THR ALA GLY LEU GLY TYR SEQRES 2 A 280 GLY SER TRP GLU ILE ASP PRO LYS ASP LEU THR PHE LEU SEQRES 3 A 280 LYS GLU LEU GLY THR GLY GLN PHE GLY VAL VAL LYS TYR SEQRES 4 A 280 GLY LYS TRP ARG GLY GLN TYR ASP VAL ALA ILE LYS MET SEQRES 5 A 280 ILE LYS GLU GLY SER MET SER GLU ASP GLU PHE ILE GLU SEQRES 6 A 280 GLU ALA LYS VAL MET MET ASN LEU SER HIS GLU LYS LEU SEQRES 7 A 280 VAL GLN LEU TYR GLY VAL CYS THR LYS GLN ARG PRO ILE SEQRES 8 A 280 PHE ILE ILE THR GLU TYR MET ALA ASN GLY CYS LEU LEU SEQRES 9 A 280 ASN TYR LEU ARG GLU MET ARG HIS ARG PHE GLN THR GLN SEQRES 10 A 280 GLN LEU LEU GLU MET CYS LYS ASP VAL CYS GLU ALA MET SEQRES 11 A 280 GLU TYR LEU GLU SER LYS GLN PHE LEU HIS ARG ASP LEU SEQRES 12 A 280 ALA ALA ARG ASN CYS LEU VAL ASN ASP GLN GLY VAL VAL SEQRES 13 A 280 LYS VAL SER ASP PHE GLY LEU SER ARG TYR VAL LEU ASP SEQRES 14 A 280 ASP GLU TYR THR SER SER VAL GLY SER LYS PHE PRO VAL SEQRES 15 A 280 ARG TRP SER PRO PRO GLU VAL LEU MET TYR SER LYS PHE SEQRES 16 A 280 SER SER LYS SER ASP ILE TRP ALA PHE GLY VAL LEU MET SEQRES 17 A 280 TRP GLU ILE TYR SER LEU GLY LYS MET PRO TYR GLU ARG SEQRES 18 A 280 PHE THR ASN SER GLU THR ALA GLU HIS ILE ALA GLN GLY SEQRES 19 A 280 LEU ARG LEU TYR ARG PRO HIS LEU ALA SER GLU LYS VAL SEQRES 20 A 280 TYR THR ILE MET TYR SER CYS TRP HIS GLU LYS ALA ASP SEQRES 21 A 280 GLU ARG PRO THR PHE LYS ILE LEU LEU SER ASN ILE LEU SEQRES 22 A 280 ASP VAL MET ASP GLU GLU SER SEQRES 1 D 280 GLY SER LYS ASN ALA PRO SER THR ALA GLY LEU GLY TYR SEQRES 2 D 280 GLY SER TRP GLU ILE ASP PRO LYS ASP LEU THR PHE LEU SEQRES 3 D 280 LYS GLU LEU GLY THR GLY GLN PHE GLY VAL VAL LYS TYR SEQRES 4 D 280 GLY LYS TRP ARG GLY GLN TYR ASP VAL ALA ILE LYS MET SEQRES 5 D 280 ILE LYS GLU GLY SER MET SER GLU ASP GLU PHE ILE GLU SEQRES 6 D 280 GLU ALA LYS VAL MET MET ASN LEU SER HIS GLU LYS LEU SEQRES 7 D 280 VAL GLN LEU TYR GLY VAL CYS THR LYS GLN ARG PRO ILE SEQRES 8 D 280 PHE ILE ILE THR GLU TYR MET ALA ASN GLY CYS LEU LEU SEQRES 9 D 280 ASN TYR LEU ARG GLU MET ARG HIS ARG PHE GLN THR GLN SEQRES 10 D 280 GLN LEU LEU GLU MET CYS LYS ASP VAL CYS GLU ALA MET SEQRES 11 D 280 GLU TYR LEU GLU SER LYS GLN PHE LEU HIS ARG ASP LEU SEQRES 12 D 280 ALA ALA ARG ASN CYS LEU VAL ASN ASP GLN GLY VAL VAL SEQRES 13 D 280 LYS VAL SER ASP PHE GLY LEU SER ARG TYR VAL LEU ASP SEQRES 14 D 280 ASP GLU TYR THR SER SER VAL GLY SER LYS PHE PRO VAL SEQRES 15 D 280 ARG TRP SER PRO PRO GLU VAL LEU MET TYR SER LYS PHE SEQRES 16 D 280 SER SER LYS SER ASP ILE TRP ALA PHE GLY VAL LEU MET SEQRES 17 D 280 TRP GLU ILE TYR SER LEU GLY LYS MET PRO TYR GLU ARG SEQRES 18 D 280 PHE THR ASN SER GLU THR ALA GLU HIS ILE ALA GLN GLY SEQRES 19 D 280 LEU ARG LEU TYR ARG PRO HIS LEU ALA SER GLU LYS VAL SEQRES 20 D 280 TYR THR ILE MET TYR SER CYS TRP HIS GLU LYS ALA ASP SEQRES 21 D 280 GLU ARG PRO THR PHE LYS ILE LEU LEU SER ASN ILE LEU SEQRES 22 D 280 ASP VAL MET ASP GLU GLU SER HET L9S A 701 40 HET EDO A 702 4 HET L9S D 701 40 HET EDO D 702 4 HETNAM L9S N-[2-FLUORO-6-(PYRROLIDIN-1-YL)PHENYL]-N'-{3-[(2R)-1- HETNAM 2 L9S (2-HYDROXYETHYL)-4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL) HETNAM 3 L9S PIPERAZIN-2-YL]PHENYL}UREA HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 L9S 2(C29 H33 F N8 O2) FORMUL 4 EDO 2(C2 H6 O2) FORMUL 7 HOH *497(H2 O) HELIX 1 AA1 ASP A 398 LYS A 400 5 3 HELIX 2 AA2 SER A 438 ASN A 451 1 14 HELIX 3 AA3 LEU A 482 GLU A 488 1 7 HELIX 4 AA4 MET A 489 ARG A 492 5 4 HELIX 5 AA5 GLN A 494 LYS A 515 1 22 HELIX 6 AA6 ALA A 523 ARG A 525 5 3 HELIX 7 AA7 GLY A 541 VAL A 546 5 6 HELIX 8 AA8 ASP A 548 SER A 553 1 6 HELIX 9 AA9 PRO A 560 SER A 564 5 5 HELIX 10 AB1 PRO A 565 SER A 572 1 8 HELIX 11 AB2 SER A 575 SER A 592 1 18 HELIX 12 AB3 THR A 602 GLN A 612 1 11 HELIX 13 AB4 SER A 623 CYS A 633 1 11 HELIX 14 AB5 LYS A 637 ARG A 641 5 5 HELIX 15 AB6 THR A 643 GLU A 658 1 16 HELIX 16 AB7 ASP D 398 LYS D 400 5 3 HELIX 17 AB8 SER D 438 ASN D 451 1 14 HELIX 18 AB9 LEU D 482 GLU D 488 1 7 HELIX 19 AC1 MET D 489 ARG D 492 5 4 HELIX 20 AC2 GLN D 494 LYS D 515 1 22 HELIX 21 AC3 ALA D 523 ARG D 525 5 3 HELIX 22 AC4 GLY D 541 VAL D 546 5 6 HELIX 23 AC5 ASP D 548 SER D 553 1 6 HELIX 24 AC6 PRO D 560 SER D 564 5 5 HELIX 25 AC7 PRO D 565 SER D 572 1 8 HELIX 26 AC8 SER D 575 SER D 592 1 18 HELIX 27 AC9 THR D 602 GLN D 612 1 11 HELIX 28 AD1 SER D 623 CYS D 633 1 11 HELIX 29 AD2 LYS D 637 ARG D 641 5 5 HELIX 30 AD3 THR D 643 GLU D 658 1 16 SHEET 1 AA1 5 LEU A 402 THR A 410 0 SHEET 2 AA1 5 GLY A 414 TRP A 421 -1 O VAL A 416 N LEU A 408 SHEET 3 AA1 5 TYR A 425 ILE A 432 -1 O MET A 431 N VAL A 415 SHEET 4 AA1 5 PHE A 471 THR A 474 -1 O ILE A 472 N LYS A 430 SHEET 5 AA1 5 LEU A 460 CYS A 464 -1 N GLY A 462 O ILE A 473 SHEET 1 AA2 3 GLY A 480 CYS A 481 0 SHEET 2 AA2 3 CYS A 527 VAL A 529 -1 O VAL A 529 N GLY A 480 SHEET 3 AA2 3 VAL A 535 VAL A 537 -1 O LYS A 536 N LEU A 528 SHEET 1 AA3 5 LEU D 402 THR D 410 0 SHEET 2 AA3 5 GLY D 414 TRP D 421 -1 O VAL D 416 N LEU D 408 SHEET 3 AA3 5 TYR D 425 ILE D 432 -1 O MET D 431 N VAL D 415 SHEET 4 AA3 5 PHE D 471 THR D 474 -1 O ILE D 472 N LYS D 430 SHEET 5 AA3 5 LEU D 460 CYS D 464 -1 N TYR D 461 O ILE D 473 SHEET 1 AA4 3 GLY D 480 CYS D 481 0 SHEET 2 AA4 3 CYS D 527 VAL D 529 -1 O VAL D 529 N GLY D 480 SHEET 3 AA4 3 VAL D 535 VAL D 537 -1 O LYS D 536 N LEU D 528 SITE 1 AC1 18 LEU A 408 PHE A 413 VAL A 416 ALA A 428 SITE 2 AC1 18 LYS A 430 ILE A 432 THR A 474 GLU A 475 SITE 3 AC1 18 MET A 477 ASN A 526 LEU A 528 ASP A 539 SITE 4 AC1 18 LEU A 542 VAL A 546 TYR A 551 HOH A 833 SITE 5 AC1 18 HOH A 905 HOH A 933 SITE 1 AC2 17 LEU D 408 PHE D 413 GLY D 414 VAL D 416 SITE 2 AC2 17 ALA D 428 LYS D 430 ILE D 432 THR D 474 SITE 3 AC2 17 GLU D 475 MET D 477 LEU D 528 ASP D 539 SITE 4 AC2 17 LEU D 542 VAL D 546 HOH D 834 HOH D 869 SITE 5 AC2 17 HOH D 985 SITE 1 AC3 3 THR D 403 PHE D 404 HOH D 911 CRYST1 38.297 71.709 104.410 90.00 89.95 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026112 0.000000 -0.000025 0.00000 SCALE2 0.000000 0.013945 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009578 0.00000